JACOBS LEVY EQUITY MANAGEMENT, INC

Position in CCCC — C4 Therapeutics, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in CCCC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$117,268

-$578,682 QoQ

Shares Held

25,111

-90.5% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#94

of 147 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. CCCC ranks #78 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$117,268	25,111	-90.5%	Shares	Sole	2026-08-14
2026-03-31	$695,950	264,620	-47.4%	Shares	Sole	2026-05-15
2025-09-30	$1,116,981	503,145	+13.9%	Shares	Sole	2025-11-17
2025-06-30	$631,681	441,735	-36.7%	Shares	Sole	2025-08-14
2025-03-31	$1,116,244	697,653	+595.1%	Shares	Sole	2025-05-15
2023-12-31	$567,090	100,370	-88.4%	Shares	Sole	2024-02-14
2023-09-30	$1,607,934	864,481	+18.6%	Shares	Sole	2023-11-17
2023-06-30	$2,004,587	728,941	+0.7%	Shares	Sole	2023-08-14
2023-03-31	$2,272,421	723,701	-0.7%	Shares	Sole	2023-05-15
2022-12-31	$4,299,158	728,671	-1.4%	Shares	Sole	2023-02-14
2022-09-30	$6,480,968	738,993	+38.8%	Shares	Sole	2022-11-15
2022-06-30	$4,014,446	532,420	+2174.0%	Shares	Sole	2022-08-15
2021-06-30	$885,947	23,413	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.